AI Tech & Financing For Salons & Med Spas: Fully Booked Meets Fully Funded
Fully Booked AI, front-runner in salon & med spa marketing & automation, is excited to…
News
Mitsubishi Shipbuilding to Launch Technical Studies on Ammonia Fuel Supply System for Marine Engines under Development by WinGD
TOKYO, Jun 5, 2023 – (JCN Newswire) – Mitsubishi Shipbuilding Co., Ltd., a part of…
1st Asian Para Tenpin Bowling Championships Successfully Completed, Hong Kong Team Becomes Big Winner with 10 gold, 6 silver & 2 bronze medals
HONG KONG, Jun 5, 2023 – (ACN Newswire) – The 1st Asian Para Tenpin Bowling…
Nissin Foods’ MSCI ESG rating upgraded to A
HONG KONG, Jun 5, 2023 – (ACN Newswire) – Nissin Foods Company Limited (“Nissin Foods”,…
Teleperformance Helps Clients Accelerate Business Value From Their Cloud Transformations With Two Amazon Web Services Distinctions
The company’s AI-powered, scalable, and customized business process management solutions provide faster, more personalized customer…
Elliptic Labs Launches on Motorola Razr Flip Phones – the Razr 40 and Razr 40 Ultra
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
Rovanpera increases lead with podium for TOYOTA GAZOO Racing
TOKYO, Jun 5, 2023 – (JCN Newswire) – TOYOTA GAZOO Racing World Rally Team driver…
Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial
New CHM 1101 (CLXT CAR T) multi-center clinical trial activated at Sarah Cannon Research Institute…
Mesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Role
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
The GBA Recognizes Blockchain Trailblazers
Washington, D.C., Jun 5, 2023 – (ACN Newswire) – The Government Blockchain Association (GBA) honored…
Cyxtera Takes Next Step to Implement Restructuring Support Agreement
Initiates Pre-Arranged Chapter 11 Process with Substantial Support from Lenders to Facilitate Comprehensive Balance Sheet…
Blue Yonder and nConnect Group Successfully Implement WMS Solution for Team Global Express in New Zealand
MELBOURNE, Australia & SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Team Global Express, Australia and New Zealand’s leading multi-modal logistics…
BrainChip and Lorser Industries to Develop Neuromorphic Computing Systems for Software-Defined Radio Devices
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), a global leader…
Relay Robotics Introduces Relay2, The New High-Capacity Hotel Delivery Robot
Relay2 brings 2X larger payload, customized accessories, and upgraded cloud-based elevator integration, enabling hotel owner/operators…
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69…
Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
NEW YORK–(BUSINESS WIRE)–Massive Bio, a globally recognized leader in the oncology space, has proudly announced…
New Long-Term Data from the CHRYSALIS Study Show Median Progression-Free Survival Not Reached After 33.6 Months of Follow Up with First-Line Use of RYBREVANT®▼ (amivantamab) and Lazertinib Combination Therapy in Patients with Treatment-Naïve EGFR-Mutated Advanced Non-Small Cell Lung Cancer
Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung…
Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy
– Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in…
Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice
CHICAGO–(BUSINESS WIRE)–#biomarker—Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology,…
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety…